BackgroundHigh sensitivity C-reactive protein (hs-CRP) is commonly used in clinical practice
to assess cardiovascular risk. However, a correlation has not yet been established
between the absolute levels of peripheral and central hs-CRP.ObjectiveTo assess the correlation between serum hs-CRP levels (mg/L) in a peripheral vein
in the left forearm (LFPV) with those in the coronary sinus (CS) of patients with
coronary artery disease (CAD) and a diagnosis of stable angina (SA) or unstable
angina (UA).MethodsThis observational, descriptive, and cross-sectional study was conducted at the
Instituto do Coração, Hospital das Clinicas, Faculdade de Medicina, Universidade
de São Paulo, and at the Hospital Beneficência Portuguesa de Sao Paulo, where CAD
patients referred to the hospital for coronary angiography were evaluated.ResultsForty patients with CAD (20 with SA and 20 with UA) were included in the study.
Blood samples from LFPV and CS were collected before coronary angiography.
Furthermore, analysis of the correlation between serum levels of hs-CRP in LFPV
versus CS showed a strong linear correlation for both SA (r = 0.993, p < 0.001)
and UA (r = 0.976, p < 0.001) and for the entire sample (r = 0.985, p <
0.001).ConclusionOur data suggest a strong linear correlation between hs-CRP levels in LFPV versus
CS in patients with SA and UA.
Cardiac amyloidosis is a disease that highly compromises the survival expectancy after the beginning of the symptomatic phase, usually with sudden death as the final event. The aggression to other organs, although, can make heart transplantation a disputable form of treatment taking into consideration the shortage of organ donors. The aim is to report the evolution with a survival of seven years after heart transplantation and in fair condition of a patient with amyloidosis. One year after the heart transplantation, the patient was referred to renal transplantation also in consequence of the disease aggression. The patient evolution was favorable compared to three other patients also from our service, who died early after the diagnosis. Even considering the multi-systemic nature of amyloidosis, we can accept that in selected patients the heart transplantation is justified, taking into account the very ill prognosis of the disease.Descriptors: Amyloidosis. Heart transplantation. Cardiomyopathies/surgery.
Resumo
Background: It is still very controversial whether the characteristics of pain in the acute myocardial infarction could be related to the culprit coronary artery. There are no data about associations of pain with the ST-segment elevation myocardial infarction (STEMI) and left ventricular (LV) fibrotic segments.Methods: Data from 328 participants who had STEMI and were included in the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study were analyzed. The culprit artery was identified by coronary angiography and the injured myocardial segments by cardiac magnetic resonance. The statistical significance was established by P value < 0.05.Results: A total of 223 patients (68%) were selected. Association was not observed between chest pain and the culprit artery (P = 0.237), as well as between pain irradiation and the culprit artery (P = 0.473). No significant difference was observed in the pain localization in relation to the segments in the short axis basal, mid, apical, and long axis, except for the mid inferior segment. The data were not considered clinically relevant because this association was observed in only one of 17 segments after multiple comparisons.
Conclusions:In patients with STEMI, no associations were observed between the location or irradiation of acute chest pain and/or adjacent areas and the culprit artery, or between pain and segmental myocardial fibrosis in the LV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.